Cynthia Pussinen

CEO

New York City, New York, United States31 yrs 2 mos experience

Key Highlights

  • Led commercialization of therapies generating over $5B in sales.
  • Raised over $1.5B through strategic partnerships and capital raises.
  • Recognized for aligning science and strategy for durable outcomes.
Stackforce AI infers this person is a seasoned leader in the biotech and pharmaceutical industries.

Contact

Skills

Core Skills

Executive LeadershipPharmaceutical Industry

Other Skills

Board of DirectorsPublic SpeakingBusiness TransformationBiotechnologyStrategyCross-functional Team LeadershipLife SciencesLeadershipManagementDrug DevelopmentProgram ManagementChange ManagementCDMOSales and MarketingP&L Management

About

CEO and board director with extensive global experience across biotech and pharmaceutical organizations, spanning discovery through commercialization. Trusted to lead companies through moments that matter most: formation, scale-up, capital raises, strategic partnerships, operational transformation, and governance evolution. Brings strong scientific fluency paired with disciplined execution in highly regulated environments. Known for clear decision making under pressure, constructive engagement with shareholders, and a strong sense of accountability to long-term enterprise value. Significant experience in biotech, advanced therapies, precision medicine, med tech, devices and pharmaceuticals providing strategic, operational, and functional leadership, including 6 years as a CEO, 3 years as a CTO | COO and 15+ years as a C-level or EVP | VP professional. • Led the development, licensure, commercialization and delivery of more than 15 new medical therapies to patients globally, delivering single peak year sales >$5B. • Drove a holistic turnaround of company | subsidiary operations, catapulting performance from last to first across all company subsidiaries, within ~18 months of assuming CEO | President role. • Raised non-dilutive capital through the out-license of a key asset and sale of capital assets >$300M; aggregate deal value >$1.5B • Contributed to raising and | or hard circling >$100M equity or venture debt investments for small biotech companies • Negotiated a ~$1.9B non-binding term sheet with a top 10 pharma partner • ‘Raised’ $750M-$1B from a top 10 pharma board for a significant infrastructure investment Particularly well-suited for CEO and board roles in life sciences companies facing strategic, leadership, or capital inflection points. Recognized for independent judgment, credibility with investors, and the ability to align science, strategy, and execution into durable outcomes.

Experience

Xelcis bio inc.

Member Board of Directors

Jul 2025Present · 8 mos · Greater Boston · Hybrid

Biotech ceo sisterhood

Member

Sep 2024Present · 1 yr 6 mos

Sernova

Chief Executive Officer | Member Board of Directors

Jul 2023Aug 2024 · 1 yr 1 mo

Tome biosciences

Scientific & Technical Advisory Board Member

Jun 2023Oct 2024 · 1 yr 4 mos

Owl bio advisors

CEO | Executive Advisor & Consultant | Private Equity Advisor | Board Advisor | Board Member

Jan 2023Present · 3 yrs 2 mos · Boston, New York City Metropolitan Area

  • Fractional CxO | Private Equity Advisor (life sciences and health IT industries) | Life Sciences Advisory & Strategic | Operations | Leadership | Team Based Consulting for C-Suite, Boards & Functional Leaders
Executive LeadershipPharmaceutical IndustryBoard of DirectorsPublic SpeakingBusiness Transformation

Mastercontrol

Board of Directors Advisor and Executive Consultant

Jan 2023Dec 2023 · 11 mos

Spark therapeutics, inc.

Chief Technical Officer | Spark Therapeutics Board Director (UK and Ireland)

Jan 2021Dec 2022 · 1 yr 11 mos · Philadelphia, Pennsylvania, United States · Hybrid

  • departed when CTO role was eliminated

Honeywell

Global Vice President & General Manager, Life Sciences & Specialty Chemicals

Jan 2019Jan 2020 · 1 yr · Texas, Connecticut, New Jersey

  • departed when role was eliminated in early days of COVID

Actinium pharmaceuticals, inc.

Executive Vice President, Technical Development & Operations (COO)

Jan 2018Jan 2019 · 1 yr · New York, New York, United States

Pfizer

Head of R&D Strategy & Portfolio

Jan 2016Jan 2018 · 2 yrs · Connecticut, New York, Massachusetts

  • departed when role and organization were eliminated

Ipsen

3 roles

Vice President, Technical Operations and Development

Jan 2010Jan 2010 · 0 mo

President | Chief Executive Officer, Ipsen Biosciences and Ipsen Biomeasure (Ipsen subsidiaries)

Promoted

Jan 2009Jan 2015 · 6 yrs

Senior Director, Lifecycle Leader

Jan 2009Jan 2010 · 1 yr

Pfizer

Multiple Roles in R&D | Supply Chain | CDMO | Program Management

Jan 1993Jan 2009 · 16 yrs · Connecticut, New York, Michigan, United Kingdom

  • Chief of Staff & Portfolio Leader, Worldwide Portfolio & Project Management (2008 – 2009)
  • Global Head, Logistics, Supply Chain Management (2006 – 2008)
  • Global Project Manager (2001 – 2006)
  • Formulation Development Outsourcing Account Manager (1999 – 2001)
  • Scientist, Medicinal Chemistry (1993 – 1999)

Education

Rensselaer Polytechnic Institute

Master of Science - MS

University of Connecticut

Bachelor of Science (B.S.) Chemistry — A.S Nuclear Engineering

Harvard Online

Divinity and Theological Studies

Apr 2025Present

Stackforce found 100+ more professionals with Executive Leadership & Pharmaceutical Industry

Explore similar profiles based on matching skills and experience